Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Scientific Advisor at Biopact Ventures
Scientific Advisory Board for Bio-Pact Ventures.
Vice President of Pharmaceutical Development STA Pharmaceutical Co., Ltd.
(A WuXi AppTec Company) responsible for providing scientific leadership in the areas of Developability, Formulation Development and GMP Manufacturing. Ultimately responsible for the execution of all parenteral and oral dosage form programs and maintaining key client partnerships. Assess new technologies and through partnering or M&A build the capacity internally.
Global Head of Chemical and Pharmaceutical Profiling (CPP) at Novartis from 2004 to 2015. Responsibilities include analytics, solid state chemistry, formulation development and drug delivery of the entire Novartis early R&D portfolio. Lead the development and implementation of innovative dosage form designs and continuous manufacturing paradigms. Assess and manage external activities, academic and non-academic, involving the development of novel drug delivery technologies, devices, remote patient monitoring, eHealth and manufacturing technologies. Worked closely with Novartis BD&L and Venture Fund on many external deals such as Proteus Digital Health, MicroChips, 7th Sense Bio, West Pharma , Unilife, MIT and University of Toronto to mention a few.
Currently holds the position of Adjunct Professor at Massachusetts College of Pharmacy.
Previously held positions include the Director of Formulation Development at Vertex Pharmaceuticals, Director of Research and Development at Symbollon Pharmaceuticals and Senior Scientist at Biogen. He started his career at Bausch & Lomb in the pre-formulation lab and was promoted to Manger of Process Development.
His education includes two post doctoral fellowships at University of California at Santa Barbara and the Ontario Cancer Institute. He received his Ph.D. in Physical Organic Chemistry from the University of Toronto.